The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

United Therapeutics Corporation , a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

The evolution of genetic modulation of living beings using technologies such as CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) provide the creation of genetically modified ...

Scientists have discovered a new virus in American shrews and have raised concerns about its potential ability to infect ...

The second person ever has received a transplant with a genetically modified pig kidney.

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...